Accelerin (factor V) , the catobolic product of fibrinogen
Chulkova, T.; Victoreo, L.
Biulleten' Eksperimental'noi Biologii i Meditsiny 82(8): 950-952
1976
ISSN/ISBN: 0365-9615 PMID: 1026295 Document Number: 99992
The authors describe a method of obtaining a highly active and well purified human Ac-globulin (factor Y) preparation. Factor Y proved to be a part of the fibrinogen molecule--its intermediate transformation product under the effect of thrombin or some other enzyme analogous by its action.
Document emailed within 1 workday
Related Documents
Hiura, H. 2004: Fibrinogen (factor I) and dys (functional) -fibrinogen Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 12): 597-599Manwaring, D.; Thorning, D.; Curreri, P.W. 1978: Mechanisms of acute pulmonary dysfunction induced by fibrinogen degradation product D Surgery 84(1): 45-54
Takagi, K.; Kawai, T. 1978: Radioimmunoassay of an early plasmin degradation product of human fibrinogen, "fragment A", and its clinical application Thrombosis and Haemostasis 39(1): 1-11
Takagi, K.; Kawai, T. 1977: A simple and practical method for isolation of an early plasmin degradation product of human fibrinogen Thrombosis and Haemostasis 37(3): 464-470
Billon, S.; Escoffre-Barbe, M.; Mercier, B.; Abgrall, J.F.; Ferec, C. 1999: Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients Thrombosis and Haemostasis 81(4): 659-660
Egbring, R.; Schmidt, W.; Havemann, K. 1973: Etiology of factor XIII, factor V and fibrinogen deficiency in acute leukemias Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1351-1354
Princen, H.M.; Moshage, H.J.; Emeis, J.J.; de Haard, H.J.; Nieuwenhuizen, W.; Yap, S.H. 1985: Fibrinogen fragments X, Y, D and e increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats Thrombosis and Haemostasis 53(2): 212-215
Liu, D.Y.; Rosen, S. 1994: Activation of bovine factor IX by the reaction product of bovine factor VIi and human tissue factor Chinese Medical Journal 107(3): 181-185
Giannasi, G.; Ferrari, S.; Galetta, F. 1995: Fibrinogen as a cardiovascular risk factor Minerva Cardioangiologica 43(5): 169-175
Ferrara, E.; Cucchi, G.; Sardeo, C. 1989: Fibrinogen, a cardiovascular risk factor Minerva Cardioangiologica 37(11): 473-475
Göbel, U.; Petrich, C.; Schmidt, E. 1973: Prothrombin, accelerin and convertin in healthy and sick newborn infants Helvetica Paediatrica Acta 28(4): 291-299
Ogawa, K.; Baba, S.; Funazaki, K.; Nakanishi, K.; Hirohashi, K.; Suzuki, E.; Tamura, M. 1984: The values of plasminogen, antithrombin III, factor XIIi and fibrinogen according to age and sex Rinsho Byori. Japanese Journal of Clinical Pathology 32(6): 679-682
Tani, M.; Bossini, S.; Maffetti, G. 1991: Fibrinogen and factor VIi levels in patients under estrogen-progestin therapy Minerva Ginecologica 43(11): 519-524
Shainoff, J.R.; DiBello, P.M. 2003: Cross-linking of fibrinogen by factor XIIi zymogen is not apparent in vivo Thrombosis and Haemostasis 89(5): 943
Harris, P.J. 1982: Neutrophil product with lymphocyte activating factor activity Clinical and Experimental Immunology 50(3): 474-478
Hummel, L. 1993: Importance of the fibrinogen concentration as an independent risk factor for ischemic heart disease Wiener Medizinische Wochenschrift 143(18): 469-472
Erlandsson, E.; Winstedt, D.; Tornqvist, F.; Frigyesi, A.; Schött, U. 2011: Fibrinogen--critical factor in massive bleeding. A retrospective study of management in trauma Lakartidningen 108(44): 2219-2223
Mehta, R.C.; Smith, S.R.; Grove, G.L.; Ford, R.O.; Canfield, W.; Donofrio, L.M.; Flynn, T.C.; Leyden, J.J. 2008: Reduction in facial photodamage by a topical growth factor product Journal of Drugs in Dermatology: Jdd 7(9): 864-871
Kätzel, R.; Kubel, M.; Scheel, H.; Wegner, H. 1978: Results of in vivo analysis of injected fibrinogen degradation products and factor VIIi in patients with hemophilia a Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 33(15): 525-529
Primrose, J.N.; Davies, J.A.; Prentice, C.R.; Hughes, R.; Johnston, D. 1992: Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity Thrombosis and Haemostasis 68(4): 396-399